USA finally is set up the first vaccine trial to human for the elimination of COVID19. The vaccine has a generic name “mRNA1273”, the world is waiting for this to end the crisis of world pandemic.

“The open-label trial will enroll 45 healthy adult volunteers’ ages 18 to 55 years over approximately 6 weeks,” the NIH said. “The first participant received the investigational vaccine today.”

The said vaccine is developed by US National Institute of Health (NIH) with the full participation of scientist and collaborators at Biotechnology Company “Moderna” located at Massachusetts Cambridge.

The said trial will be participated by 45 adult with the age ranges from 18 to 55 years old.

This is the first phase of the vaccine and a will be expected on the market for almost a year or 18 months more, but it is still a good news.

Coronaviruses appearance is in a circular body wearing a crown “corona”.

Its origin is from Wuhan China and almost months is rapid spread causes lockdown of the city.

WHO declares COVID19 as global pandemic and said to be deadly on the elderly people worsen by people with underlying conditions like asthma, hypertension and diabetes.

Different pharmaceutical company is on tight competition on formulating the first approved vaccine against COVID19 and also the race against time the early the better.